Essential functions of regulatory T cell TGF-β1 revealed by differential gene-targeting approaches
- PMID: 33691127
- PMCID: PMC8268040
- DOI: 10.1016/j.immuni.2021.02.005
Essential functions of regulatory T cell TGF-β1 revealed by differential gene-targeting approaches
Conflict of interest statement
Declaration of interests T.A.C. is an inventor on published US patent no. US10391131B2, submitted by The Brigham and Women’s Hospital, Inc. and Children’s Medical Center Corporation, which covers methods and compositions for prevention and treatment of food allergy using microbial treatments. T.A.C. and E.S.-V. have pending patent applications related to the use of probiotics in enforcing oral tolerance in food allergy (no. 62/798,224). T.A.C. is a co-founder and has equity in Paretobio.
Figures
Comment on
-
Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity.Immunity. 2020 Dec 15;53(6):1202-1214.e6. doi: 10.1016/j.immuni.2020.10.002. Epub 2020 Oct 20. Immunity. 2020. PMID: 33086036 Free PMC article.
References
-
- Choi G, Kim B-S, Chang J-H, and Chung Y (2021). Defining the role of transforming growth factor b1 in Foxp3+ T regulatory Cells. Immunity 54, 393–394. - PubMed
-
- Velegraki M, Salem M, Ansaa-Addo EA, Wu BX, and Li Z (2021). Autocrine transforming growth factor b1 in regulatory T cell biology—gone but not missed. Immunity 54, 395–396. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
